Brief: Revelation Biosciences And Vanderbilt University Enter Exclusive Worldwide License Agreement
06/10/2022 12:06
Oct 6 (Reuters) - Revelation Biosciences Inc REVB.O :
* REVELATION BIOSCIENCES INC. AND VANDERBILT UNIVERSITY
ENTER
EXCLUSIVE WORLDWIDE LICENSE AGREEMENT
* REVELATION BIOSCIENCES INC- AGREEMENT TO DEVELOP AND
COMMERCIALIZE PHOSPHORYLATED HEXAACYL DISACCHARIDE (PHAD), FOR
TREATING OR PREVENTING INFECTIONS
* REVELATION BIOSCIENCES INC- CO AND VANDERBILT UNIVERSITY
WILL
CONTINUE PROSECUTION OF ADDITIONAL PATENT APPLICATIONS
Source text for Eikon: ID:nBw4717nfa
Further company coverage: REVB.O
((Reuters.Briefs@thomsonreuters.com;))